Is White Blood Cell Reduction Equivalent to Antibody Screening in Preventing Transmission of Cytomegalovirus by Transfusion? A Review of the Literature and Meta-Analysis
- 1 July 2005
- journal article
- research article
- Published by Elsevier in Transfusion Medicine Reviews
- Vol. 19 (3) , 181-199
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Prevention of post-transfusion cytomegalovirus: leucoreduction or screening?Vox Sanguinis, 2002
- The cytomegalovirus-“safe” blood product: Is leukoreduction equivalent to antibody screening?Transfusion Medicine Reviews, 2000
- Prevention of transfusion‐associated cytomegalovirus infection in neonatal patients by the removal of white cells from bloodTransfusion, 1992
- Indications for the Use of Cytomegalovirus-Seronegative Blood ProductsTransfusion Medicine Reviews, 1991
- Prevention of primary cytomegalovirus infection in patients with hematologic malignancies by intensive white cell depletion of blood productsTransfusion, 1989
- USE OF LEUCOCYTE‐POOR BLOOD COMPONENTS TO PREVENT PRIMARY CYTOMEGALOVIRUS (CMV) INFECTION IN PATIENTS WITH ACUTE LEUKAEMIABritish Journal of Haematology, 1988
- Meta-analysis in clinical trialsControlled Clinical Trials, 1986
- Posttransfusion cytomegalovirus infection in neonates: Role of saline-washed red blood cellsThe Journal of Pediatrics, 1986
- Cytomegalovirus Immune Globulin and Seronegative Blood Products to Prevent Primary Cytomegalovirus Infection after Marrow TransplantationNew England Journal of Medicine, 1986
- Prevention of transfusion-acquired cytomegalovirus infections in newborn infantsThe Journal of Pediatrics, 1981